EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease

Xavier G L V Pouwels, Suzanne Holewijn, Daphne van der Veen, Mauricio Gonzalez-Urquijo, Michel M P J Reijnen, Hendrik Koffijberg

The European Journal of Health Economics · 2026-03 · 27 (2) · 277-287

DOI: 10.1007/s10198-025-01792-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, online erschienen am 30.07.2025. Verfasst von Xavier G L V Pouwels und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Health Technology and Services Research, TechMed Centre, Faculty of Behavioural, Management, and Social Sciences, University of Twente, En…. Hauptthemen laut MEDLINE: Stents, Endovascular Procedures, Iliac Artery, Arterial Occlusive Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Getinge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the cost effectiveness of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) versus kissing stents (KS) and open surgical repair (OSR) for treating extensive aorto-iliac occlusive disease (AIOD).

Methods

A decision tree followed by a health state transition model was developed to simulate changes in Rutherford status and the occurrence of reinterventions, amputation, and death. A Dutch health care perspective and a five-year time horizon were used. Model inputs were estimated using non-randomised data of individuals who underwent a CERAB or a KS procedure and literature. The total number of reinterventions, life years, quality-adjusted life years (QALYs) and health care costs per strategy were calculated as well as the incremental costs and QALYs between strategies, and corresponding incremental cost-effectiveness ratios (ICERs).

Results

OSR resulted in the lowest survival due to a higher peri-operative probability of death. OSR resulted in a lower probability of reinterventions (6%, 95% Confidence Interval (CI): 1-15%) than CERAB (17%, 95%CI: 11-27%) and KS (29%, 95%CI: 17-46%). CERAB dominated OSR since it led to 0.032 (95%CI: -0.038-0.082) incremental QALYs and €-11,466 (95%CI: €-18,934-€-3,415) incremental costs versus OSR. CERAB led to 0.048 (95%CI: 0.011–0.109) incremental QALYs, €5,324 (95%CI: €2,938-€10,397) incremental costs, and an ICER of €110,201 per QALY versus KS.

Conclusions

CERAB dominated OSR and resulted in the highest health benefits and costs but does not seem to be cost effective versus KS for treating AIOD. Performing a randomised comparison of these treatment modalities is essential to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StentsEndovascular ProceduresIliac ArteryArterial Occlusive DiseasesAortic DiseasesHumansCost-Benefit AnalysisQuality-Adjusted Life YearsDecision TreesMaleNetherlandsFemaleAgedMiddle AgedCost-Effectiveness Analysis

Stichwörter der Autor:innen

Arterial occlusive diseasesCost-effectiveness analysisEconomic modelEndovascular proceduresQuality-adjusted life years

Autor:innen und Institutionen

  • Section of Health Technology and Services Research, TechMed Centre, Faculty of Behavioural, Management, and Social Sciences, University of Twente, Enschede, The Netherlands. x.g.l.v.pouwels@utwente.nl.
  • Department of Surgery, Rijnstate, Arnhem, The Netherlands.
  • Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexico.
  • Multi-Modality Medical Imaging Group, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
  • Section of Health Technology and Services Research, TechMed Centre, Faculty of Behavioural, Management, and Social Sciences, University of Twente, Enschede, The Netherlands.

Förderung

  • Getinge

Zitieren

APA

Pouwels, X. G. L. V., Holewijn, S., Veen, D. V., Gonzalez-Urquijo, M., Reijnen, M. M. P. J., & Koffijberg, H. (2026). Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease. The European Journal of Health Economics, 27(2), 277-287. https://doi.org/10.1007/s10198-025-01792-5

Vancouver

Pouwels XGLV, Holewijn S, Veen DV, Gonzalez-Urquijo M, Reijnen MMPJ, Koffijberg H. Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease. The European Journal of Health Economics. 2026;27(2):277-287. doi:10.1007/s10198-025-01792-5

BibTeX
@article{Pouwels2026,
  author = {Pouwels, Xavier G L V and Holewijn, Suzanne and Veen, Daphne van der and Gonzalez-Urquijo, Mauricio and Reijnen, Michel M P J and Koffijberg, Hendrik},
  title = {Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease},
  journal = {The European Journal of Health Economics},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {277--287},
  doi = {10.1007/s10198-025-01792-5}
}
Kostenlos starten →